Does class switching contribute to remission in bullous pemphigoid?

Acta Dermato-Venereologica

Volumn 79, Issue 2, 1999, Pages 127-131

  Modre, B ^a   Allen, J ^a   Wojnarowska, F ^a,b  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Clinical activity; IgG subclass; IgG1; IgG4; Subepidermal immunobullous diseases

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE SWITCHING; HUMAN; IMMUNOPHENOTYPING; MALE; PEMPHIGOID; PRIORITY JOURNAL;

EID: 0033005483     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155599750011345     Document Type: Article

References (38)

1. Person JR, Rogers RS. Bullous and cicatricial pemphigoid. Clinical, histopathologic and immunopathologic correlations. Mayo Clin Proc 1977; 52: 54-66.
2. Ahmed AR, Newcomer VD. Bullous Pemphigoid: clinical features. In: Ahmed AR, ed. Clinics in dermatology. Philadelphia: Lippincott JB, 1987: 6-12.
3. Gooptu C, Kaur V, Wojnarowska F. Dermato-epidemiology of the immunobullous diseases. In: Williams HC, Strachan D, eds. The challenge of dermato-epidemiology. New York: CRC Press, 1997: 223-228.
4. Mueller S, Klaus-Kovtun V, Stanley J. A 230-kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol 1989; 92: 33-38.
5. Mutasim DF, Morrison LH, Takahashi Y, Labib RS, Skouge J, Diaz LA, Anhalt GJ. Definition of bullous pemphigoid antibody binding to intercellular and extracellular antigen associated with hemidesmosomes. J Invest Dermatol 1989; 92: 225-230.
6. Guidice GJ, Emerty D, Diaz LA. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 1992; 99: 243-250.
7. Venning V, Wojnarowska F. Lack of predictive factors for the clinical course of bullous pemphigoid. J Am Acad Dermatol 1992; 26: 585-589.
8. Tanaka M, Hashimoto T. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles. Clin Exp Dermatol 1996; 21: 23-27.
9. Venning V, Whitehead PH, Leigh I, Allen J, Wojnarowska F. The clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen. Br J Dermatol 1991; 125: 561-565.
10. Flotte TJ. Pathology of pemphigoid In: Ahmed AR, ed. Clinics in dermatology. Philadelphia: Lippincott JB, 1987: 71-80.
11. Ahmed AR, Maize JC, Provost TT. Bullous Pemphigoid. Clinical and immunologic follow-up after successful therapy. Arch Dermatol 1977; 113: 1043-1046.
12. Chorzelski T, Jablonska S, Blaszezyk M, Jarzabek M. Autoantibodies in bullous pemphigoid. Dermatologica 1968; 136: 325-334.
13. Sams WM, Jordan RE. Correlation of pemphigoid and pemphigus antibody with activity of disease. Br J Dermatol 1971; 84: 7-13.
14. Hadi SM, Barnetson RStC, Gawkrodger DJ. Clinical, histological and immunological studies in 50 patients with bullous pemphigoid. Dermatologica 1988; 176: 6-17.
15. Kirtschig G, Venning VA, Wojnarowska F. Long term studies in bullous pemphigoid: characterising the target antigen(s). Br J Dermatol 1990; 123: 835.
16. Anhalt GC, Bahn CF, Labib RS. Voorhees JJ, Sugar A, Diaz LA. Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium. J. Invest Dermatol 1981; 68: 1097-101.
17. Naito K, Morioka S, Hideoki O. The pathogenic mechanisms of blister formation in bullous pemphigoid. J Invest Dermatol 1982; 79: 303-306.
18. Liu Z, Diaz LA, Troy J. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen BP180. J Invest Dermatol 1993; 92: 2480-2488.
19. Ishizaka T, Ishizaka K, Salmon S, Fudenberg HE. Biologic activities of aggregated gamma-globulin. 8 Aggregated immunoglobulin of different classes. J Immunol 1967; 99: 82-91.
20. Zee JS, Swieten P, Aalberse RC. Serological aspects of IgG4 antibodies. J Immunol 1986; 137: 3566-3571.
21. Garcia BE, Sanz ML, Gato JJ, Fernandez J, Oehling A. IgG4 blocking effect on the release of antigen-specific histamine. J Invest Allergol Clin Immunol 1993; 3: 26-33.
22. Yamada H, Hashimoto T, Nishikawa T. IgG subclasses of intercellular and basement membrane zone antibodies: the relationship to the capability of complement fixation. J Invest Dermatol 1989; 92: 585-587.
23. Kelly S, Wojnarowska F. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Br J Dermatol 1988; 118: 31-40.
24. Stanley J. A specific antigen antibody interaction triggers the cellular pathophysiology of bullous pemphigoid. Br J Dermatol 1985; 28: 67-73.
25. Lui Z, Guidice GJ, Swarh SJ, Fairley JA, Till GO, Troy JL, Diaz LA. The role of complement in experimental bullous pemphigoid. J Clin Invest 1995; 95: 1539-1544.
26. Roujeau JC, Morel P, Dalle E. Plasma exchange in bullous pemphigoid. Lancet 1984; ii: 486-489.
27. Goldberg NS, Robinson JK, Roenigk JR. Plasmapheresis therapy for bullous pemphigoid. Arch Dermatol 1985; 121: 1484-1485.
28. Outschoorn I, Rowley MJ, Cook AD, Mackay IR. Subclasses of immunoglobulins and autoantibodies in autoimmune diseases. J Clin Immunol and Immunopathol 1993; 66: 59-66.
29. Haustein UF, Lohrisch I, Herrmann K. Pathogenetic studies in bullous pemphigoid review of literature and our own results. J Dermatol 1984; 11: 508-518.
30. Bird P, Friedmann PS, Ling N, Bird AG, Thompson RA. Subclass distribution of IgG autoantibodies in bullous pemphigoid. J Invest Dermatol 1986; 86: 21-25.
31. Soh H, Hosokawa H, Miyauchi H, Izumi H, Asada Y. The distribution of IgG subclass autoantibodies in bullous pemphigoid analysed by immunofluorescence and immunoblotting. Arch Dermatol Res 1991; 283: 400-404.
32. Kumar V, Valeski JE, Chorzelski TP, Jablonska S. Significance of IgG subclass determinations in bullous pemphigoid. J Clin Lab Anal 1996: 432-434.
33. Bernard P, Prost C, Aucouturier P, Durepaire N, Denis F, Bonnetblanc JM. The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita. J Invest Dermatol 1991; 97: 259-263.
34. Kelly SE, Cerio R, Bhogal BS, Black BB. The distribution of IgG subclasses in Pemphigoid Gestationis: PG factor is an IgG1 autoantibody. J Invest Dermatol 1989; 92: 695-698.
35. Ogawa MM, Hashimoto T, Nishikawa T, Castro RM. IgG subclasses of intercellular antibodies in Brazilian pemphigus foliaceus- the relationship to complement fixing capability. Clin Exp Dermatol 1989; 14: 29-31.
36. David M, Katzenelson V, Hazaz B, Ben-Chetrit A, Sandbank M. Determination of IgG subclasses in patients with pemphigus with active disease and in remission. Arch Dermatol 1989; 125: 787-790.
37. Wilson CL, Wojnarowska F, Dean D, Pasricha JS. IgG subclasses in Pemphigus in Indian and UK populations. Clin Exp Dermatol 1993; 18: 226-230.
38. Jones CC, Hamilton RG, Jordan RE. Subclass distribution of human autoantibodies in pemphigus. J Clin Immunol 1988; 8: 43-49.